Company Announcements

EQS-News: Solar power for Gerresheimer site in Momignies, Belgium

Source: EQS

EQS-News: Gerresheimer AG / Key word(s): ESG
Solar power for Gerresheimer site in Momignies, Belgium

14.10.2024 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Solar power for Gerresheimer site in Momignies, Belgium

  • 2.3 MWp rooftop photovoltaic system on production building
  • Gerresheimer increases share of green electricity in its energy supply
  • Goal for 2030: 100% electricity from renewable sources

Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a global partner for the pharma, biotech and cosmetic industries has successfully installed a photovoltaic system at its site in Momignies, Belgium. Gerresheimer produces glass flacons and jars for the cosmetics industry with its roughly 750 employees in Momignies. With an installed capacity of 2.3 MWp, it will produce around 2,100 MWh of solar power each year and is expected to save roughly 300 tons of CO2 compared to sourcing conventional electricity in Belgium. Almost 100% of the electricity generated will be used on site. Installing PV systems on suitable rooftops like at the Momignies site and concluding power purchase agreements with wind and solar park operators are key steps to helping Gerresheimer continually increase the share of green electricity in its energy supply. Gerresheimer has set ambitious sustainability goals as part of its formula g corporate strategy. By 2030, the company aims to switch its entire electricity supply to renewable sources.

“The photovoltaic system in Momignies is a great example of how we are gradually advancing our sustainability goals,” explains Dietmar Siemssen, CEO of Gerresheimer AG. “We are increasing the share of green energy in the electricity supply to our production sites while reducing our CO2 emissions in the process. Gerresheimer also benefits economically from these projects.”

Almost 100% of electricity generated used on site
The new photovoltaic system at the Momignies site covers over 15,000 m2 on the roof of a production hall – the equivalent of around two soccer fields. Almost 100% of the green electricity produced by the PV system is used on site. Only any peak loads are fed into the public grid. Expansion to other areas is already being considered.

By the end of 2024, the share of electricity from renewable sources at the Momignies site will increase to around 25%, including the energy produced by the new PV system. Due to its energy-intensive glass production, the site in Momignies is one of the Gerresheimer sites with high energy demand. The total share of energy from renewable sources across all 35 production sites around the globe had already reached 45.6% by the end of 2023.

High-quality and sustainable glass packaging for the cosmetics industry
The Gerresheimer site in Momignies, Belgium, specializes in the production and decoration of glass flacons and jars as primary packaging for perfume, skin and body care products. Gerresheimer uses up to 40% post-consumer recycled glass (PCR) to produce these products. Using PCR conserves resources and reduces energy consumption in the production of high-quality primary packaging solutions.

Transparent sustainability reporting
In addition to publishing a sustainability report every year, Gerresheimer also discloses relevant data as part of the ratings issued by CDP, EcoVadis, and other organizations. MSCI, Sustainalytics and ISS also evaluate Gerresheimer’s sustainability performance An overview of Gerresheimer’s external sustainability ratings can be found here.

 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated revenues of around €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).  
www.gerresheimer.com 

Contact Gerresheimer AG 

Jutta Lorberg
Head of Corporate Communication
P +49 211 6181 264
jutta.lorberg@gerresheimer.com


Marion Stolzenwald
Senior Manager Corporate Communication
P +49 1722424185
marion.stolzenwald@gerresheimer.com

 



14.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2007881

 
End of News EQS News Service

2007881  14.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2007881&application_name=news&site_id=acquiremedia~~~1e491ff3-7da4-4be1-bc7b-b8628d89203e